Mailman School of Public Health, ICAP-Columbia University, New York, New York, United States of America.
PLoS One. 2012;7(5):e37125. doi: 10.1371/journal.pone.0037125. Epub 2012 May 15.
Despite recent changes to expand the ART eligibility criteria in sub-Saharan Africa, many patients still initiate ART in the advanced stages of HIV infection, which contributes to increased early mortality rates, poor patient outcomes, and onward transmission.
To evaluate individual and clinic-level factors associated with late ART initiation in Mozambique, we conducted a retrospective sex-specific analysis of data from 36,411 adult patients who started ART between January 2005 and June 2009 at 25 HIV clinics in Mozambique. Late ART initiation was defined as CD4 count<100 cells/µL or WHO stage IV. Mixed effects models were used to identify patient- and clinic-level factors associated with late ART initiation.
The proportion of patients initiating ART late decreased from 46% to 37% during 2005-2007, but remained constant (between 37-33%) from 2007-2009. Of those who initiated ART late (median CD4 = 57 cells/µL), 5% were known to have died and 54% were lost to clinic within 6 months of ART initiation (compared with 2% and 47% among other patients starting ART [median CD4 = 192 cells/µL]). In multivariate analysis, female sex and pregnancy at ART initiation (AOR(female_not_pregnant_vs._male) = 0.66, 95%CI [0.62-0.69]; AOR(pregnant_vs._non_pregnant) = 0.60, 95%CI [0.49-0.73]), younger and older age (AOR(15-25_vs.26-30) = 0.86, 95%CI [0.79-0.94], AOR(>45_vs.26-30) = 0.72, 95%CI [0.67-0.77]), entry into care via PMTCT (AOR(entry_through_PMTCT_vs.VCT) = 0.42, 95%CI [0.35-0.50]), marital status (AOR(married/in union_vs.single) = 0.87, 95%CI [0.83-0.92]), education (AOR(secondary_or_higher_vs.primary) = 0.87, 95%CI [0.83-0.93]) and year of ART initiation were associated with a lower likelihood of late ART initiation. Clinic-level factors independently associated with a lower likelihood of late ART initiation included CD4 machine on-site (AOR(CD4_machine_onsite_vs.offsite) = 0.83, 95%CI [0.74-0.94]) and presence of PMTCT services onsite (AOR = 0.85, 95%CI [0.77-0.93]).
The risk of starting ART late remained persistently high. Efforts are needed to ensure identification and enrollment of patients at earlier stages of HIV disease. Individual and clinic level factors identified may provide clues for upstream structural interventions.
尽管最近扩大了撒哈拉以南非洲地区接受抗逆转录病毒治疗(ART)的标准,但仍有许多患者在艾滋病病毒感染的晚期开始接受抗逆转录病毒治疗,这导致早期死亡率升高、患者预后较差以及病毒继续传播。
为了评估莫桑比克与晚期开始抗逆转录病毒治疗相关的个体和诊所层面的因素,我们对 2005 年 1 月至 2009 年 6 月期间在莫桑比克 25 个艾滋病毒诊所开始接受抗逆转录病毒治疗的 36411 名成年患者进行了回顾性性别特异性分析。晚期开始抗逆转录病毒治疗定义为 CD4 计数<100 个细胞/µL 或世界卫生组织(WHO)第四期。采用混合效应模型确定与晚期开始抗逆转录病毒治疗相关的患者和诊所层面的因素。
在 2005-2007 年期间,开始晚期抗逆转录病毒治疗的患者比例从 46%降至 37%,但从 2007-2009 年期间保持不变(37%-33%)。在晚期开始抗逆转录病毒治疗的患者中(中位 CD4 = 57 个细胞/µL),有 5%已知已死亡,并且在开始抗逆转录病毒治疗后 6 个月内有 54%的患者失访(相比之下,其他开始抗逆转录病毒治疗的患者中这一比例为 2%和 47%,中位 CD4 = 192 个细胞/µL)。在多变量分析中,女性和艾滋病病毒感染期间怀孕(比值比(female_not_pregnant_vs._male)= 0.66,95%置信区间[0.62-0.69];比值比(pregnant_vs._non_pregnant)= 0.60,95%置信区间[0.49-0.73])、年龄较大和较小(比值比(15-25_vs.26-30)= 0.86,95%置信区间[0.79-0.94],比值比(>45_vs.26-30)= 0.72,95%置信区间[0.67-0.77])、通过预防母婴传播途径进入护理(比值比(entry_through_PMTCT_vs.VCT)= 0.42,95%置信区间[0.35-0.50])、婚姻状况(比值比(married/in union_vs.single)= 0.87,95%置信区间[0.83-0.92])和抗逆转录病毒治疗开始年份与较低的晚期抗逆转录病毒治疗开始可能性相关。与较低的晚期抗逆转录病毒治疗开始可能性独立相关的诊所层面因素包括现场的 CD4 检测设备(比值比(CD4_machine_onsite_vs.offsite)= 0.83,95%置信区间[0.74-0.94])和现场提供预防母婴传播服务(比值比= 0.85,95%置信区间[0.77-0.93])。
晚期开始抗逆转录病毒治疗的风险仍然很高。需要努力确保在艾滋病病毒疾病的早期阶段识别和纳入患者。确定的个体和诊所层面的因素可能为上游结构干预提供线索。